The accumulation of cells at the G2/M checkpoint at the later points of HC treatment may be due to the increased oxidation, which depleted the cellular GSH pool, causing a GSH deficiency and altering the levels of CYCs and CDKs necessary for G2/M transition. The gene discussed is CYCS; the disease is reduced glutathione measurement.